Ramius Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-161,770
Closed -$15M 361
2021
Q4
$15M Buy
+161,770
New +$10.7M 5.27% 4

Ramius Advisors's ARNA Position: Q1 2022 in Review

Ramius Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 161,770 shares — an estimated $15M sold.

Ramius Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $15M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Ramius Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Ramius Advisors sold 161,770 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $15M.
  • Ramius Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Ramius Advisors's Arena Pharmaceuticals Inc position peaked at $15M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Ramius Advisors's 13F filing for Q1 2022, filed 16 May 2022.